Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on December 8, 2025

Origins Texas Recovery Now In-Network with Optum / United Behavioral Health
Texas 2036 Board of Directors Welcomes Three New Members
New Medical Assistant Training Program Coming to Beaumont This Winter
Dentistry Today Magazine Names Dr. Dan Holtzclaw of Austin, Texas to 2026 'Leaders in Continuing Dental Education' List
Flower Turbines Announces Grant of Patent on Data Center Energy and Air Systems
“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List
Boon-Chapman Welcomes Healthcare Leader Kimberlee Langford as Vice President, Medical Management
Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting
Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in…
Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
Protara Announces Closing of $75 Million Public Offering
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
Kymera Therapeutics Announces Proposed Public Offering

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions